Sci Simple

New Science Research Articles Everyday

# Biology # Bioengineering

Microneedles: The Future of Vaccination?

Discover how microneedles may reshape vaccine delivery.

Aidan Leyba, Alexandra Francian, Mohammad Razjmoo, Amelia Bierle, Ranjith Janardhana, Nathan Jackson, Bryce Chackerian, Pavan Muttil

― 8 min read


Microneedles Transform Microneedles Transform Vaccination delivery forever. Tiny needles could change vaccine
Table of Contents

Vaccination has played a vital role in protecting people from infectious diseases for over 200 years. It has saved many lives and reduced the spread of illnesses like measles, polio, and smallpox. However, as new vaccines are developed, the process of getting these vaccines to people has become complicated. This includes storing them in the right conditions, transporting them safely, and ensuring that they are given correctly.

Most vaccines need to be kept cold to remain effective. This is known as “cold chain management.” It requires specialized equipment and trained personnel to keep the vaccines at the right temperatures from the time they leave the manufacturer until they are given to individuals. For example, during the COVID-19 pandemic, many countries faced difficulties storing and distributing new mRNA vaccines, especially those with less access to resources.

The Issues with Needles

The traditional way to give vaccines is through needles. Unfortunately, this method comes with its own set of problems. First, it requires healthcare workers who are properly trained. In many countries with fewer resources, there is often a shortage of these professionals. This can lead to accidents with needles, where healthcare workers may accidentally stick themselves or others, leading to the risk of spreading infections.

Additionally, a lot of people are afraid of needles. In the United States alone, millions of people fear needles, causing them to avoid getting vaccinated. If vaccination methods do not change, countries with limited resources will struggle to vaccinate their populations effectively. Growth in population, along with poor transportation options, makes it difficult to deliver vaccines to remote areas in a timely manner.

Alternatives to Traditional Vaccination

Researchers are constantly looking for new ways to give vaccines that do not involve needles. Some alternatives being explored include oral vaccines, patches that dissolve on the skin, and even inhaled vaccines. One exciting option is using Microneedles, which are tiny needles that can deliver vaccines through the skin with minimal discomfort.

Microneedles (MNs) are tiny compared to standard needles and can be designed to be pain-free. They come in an array of tiny tips, making them easier to use and potentially safer. Since many people are afraid of needles, MNs offer a way to deliver vaccines without the associated fear of traditional needles. They can even be designed to be self-administered, meaning that trained personnel may not be required for administering the vaccine.

One of the benefits of MNs is that they can be made from materials that do not require strict temperature controls. This means they can be stored more easily and are less likely to lose their effectiveness even in warmer conditions. Research has shown that vaccines delivered using MNs can retain their potency for long periods, even at room temperature.

The Science Behind Microneedles

Microneedles work by creating tiny holes in the outer layer of the skin, which allows the vaccine to reach the immune cells underneath. These immune cells are responsible for recognizing the vaccine, producing antibodies, and fighting off infections. By delivering the vaccine just beneath the skin, it can stimulate a strong immune response.

Different types of MNs exist for delivering vaccines:

  • Solid Microneedles: These create micro-pores in the skin to allow the vaccine to enter.
  • Hollow Microneedles: These can release the vaccine through tiny openings at the tips.
  • Dissolvable Microneedles: Made from materials that melt and dissolve under the skin, releasing their contents.

Dissolvable microneedles are particularly promising because they do not generate sharp waste after use. This makes them safer and easier to manage after vaccination.

Creating a New Vaccine Delivery System

In recent studies, researchers have been working on developing microneedles that can hold and deliver a new type of vaccine. These microneedles can dissolve under the skin and release the vaccine into the immune cells nearby, maximizing the immune response.

The team used a special technique to create these microneedles, which involved careful mixing of the vaccine with a polymer. Once the mixture was created, it was poured into molds to form the microneedles. After they dried, the needles were tested to ensure they were sharp enough to penetrate the skin effectively.

Testing the Efficacy of Microneedles

The researchers conducted experiments to see how well these microneedles work for delivering the vaccine. They made sure the microneedles were sharp and could effectively penetrate the skin. They also checked whether the vaccine remained stable after being loaded into the microneedles.

To ensure that the vaccines are released properly, they measured how fast the microneedles dissolve under the skin. In their experiments, they discovered that the needles dissolved efficiently and released the vaccine within minutes. This quick action is important for ensuring that the immune system can respond effectively.

They also found that the microneedles maintain the integrity of the vaccine even after being stored for an extended period at high temperatures. This is a significant benefit, especially for regions where it is challenging to keep vaccines at very low temperatures.

Getting Creative with Vaccine Delivery

One of the innovative parts of the research was loading the microneedles with a specific type of vaccine called a virus-like particle (VLP) that targets an important peptide involved in the transmission of diseases by mosquitoes. This approach may help to provide immunity against mosquito-borne diseases like dengue and Zika.

The researchers tested how well the microneedles worked in mice. They found that not only did the mice respond well to the vaccine, but the immune response lasted a long time. Overall, the microneedles delivered the vaccines just as effectively as traditional needles but with some added perks, such as less pain and less fear.

Storage, Stability, and Immunogenicity

A major focus was on how well the microneedles could hold the vaccine when stored in various conditions. They stored them at room temperature, slightly warmer temperatures, and even in refrigerated conditions. Remarkably, the microneedles and the vaccines remained stable under all these conditions.

The mice vaccinated using the microneedles showed strong immune responses. When tested for antibody levels, the results were comparable to those from traditional methods of vaccination. In short, the new microneedles delivered a vaccine that remained potent even when not kept in strict cold storage.

Overcoming the Needle Fear

Research shows that many people avoid vaccinations because they fear needles. Microneedles can relieve this fear. Since they are smaller and can be designed to be painless, many people may be more willing to get vaccinated using them. This could significantly help in achieving higher vaccination rates, especially in populations where vaccine hesitance is common.

Advantages of the Microneedle Approach

The microneedle system presents various advantages over the traditional needle approach:

  1. Less Pain: Since the needles are tiny, they cause less discomfort.
  2. Self-Administration: People could potentially administer these vaccines themselves.
  3. Less Waste: Dissolvable needles mean no sharp waste to dispose of.
  4. Storage Flexibility: These microneedles can be stored at higher temperatures without losing effectiveness.
  5. Easier to Produce: The manufacturing process for microneedles can be relatively quick.

All these features make the microneedle approach a fantastic candidate for improving vaccination efforts, especially in low-income countries.

Challenges to Consider

However, there are some challenges that need to be addressed before microneedles can be used widely:

  • Dosing Limitations: How much vaccine can be held in these tiny needles? Higher doses may require larger needle designs.
  • Storage Concerns: While the microneedles hold up well, ensuring they are stored properly to avoid humidity damage is crucial.
  • Need for Clinical Trials: Like any new medical technology, testing on humans is essential to ensure its safety and efficacy.

Future Directions in Vaccination

Looking ahead, researchers are optimistic about the potential of microneedles in vaccination. They are not just for new vaccines; existing vaccines can be reformulated for this delivery method. This could allow for easier administration and broader access to immunizations.

As the world continues to deal with the challenges of vaccine distribution, the development of robust delivery systems like microneedles could lead to a more efficient and effective way of managing vaccine rollouts. Particularly in remote or hard-to-reach areas, microneedles could provide a viable solution to immunization needs.

Conclusion

Vaccination has come a long way and continues to evolve. The introduction of microneedles holds great promise for the future of vaccine delivery, offering a less painful, more efficient, and flexible option. By making immunization more accessible, especially for those who may shy away from traditional needles, we can enhance public health across communities. Whether battling existing diseases or preparing for future pandemics, these tiny needles could be the heroes we didn't know we needed!

Original Source

Title: Formulation, Characterization, and in vivo Immunogenicity of Heat-Stabilized Dissolvable Microneedles Containing a Novel VLP Vaccine

Abstract: Since its introduction, vaccination has heavily improved health outcomes. However, implementing vaccination efforts can be challenging, particularly in low and middle-income countries with warmer climates. Microneedle technology has been developed for its simple and relatively painless applications of vaccines. However, no microneedle vaccine has yet been approved by the FDA. A few hurdles must be overcome, including the need to evaluate the safety and biocompatibility of the polymer used to fabricate these microneedles. Additionally, it is important to demonstrate reliable immune responses comparable to or better than those achieved through traditional administration routes. Scalability in manufacturing and the ability to maintain vaccine potency during storage and transportation are also critical factors. In this study, we developed vaccine-loaded dissolvable microneedles that showed preclinical immunogenicity after storage in extreme conditions. We developed our microneedles using the conventional micromolding technique with polyacrylic acid (PAA) polymer, incorporating a novel virus-like particle (VLP) vaccine targeting arboviruses. We performed characterization studies on these microneedles to assess needle sharpness, skin insertion force, and VLP integrity. We also investigated the thermostability of the vaccine after storing the microneedles at elevated temperatures for approximately 140 days. Finally, we evaluated the immunogenicity of this vaccine in mice, comparing transdermal (microneedle) with intramuscular (hypodermic needle) administration. We successfully fabricated and characterized VLP-loaded microneedles that could penetrate the skin and maintain vaccine integrity even after exposure to extreme storage conditions. These microneedles also elicited robust and long-lasting antibody responses similar to those achieved with intramuscular administration.

Authors: Aidan Leyba, Alexandra Francian, Mohammad Razjmoo, Amelia Bierle, Ranjith Janardhana, Nathan Jackson, Bryce Chackerian, Pavan Muttil

Last Update: 2024-12-20 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.12.16.628763

Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.16.628763.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

Similar Articles